retatrutide clinical data New Phase 3 just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats retatrutide clinical data FDA Approval

Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial

At the 4.8mg dose with actual treatment received, 83% of participants achieved at least 5% weight loss, 69% achieved at least 10%, and 55% achieved at least 15% reduction

Many insurance companies are beginning to cover obesity medications, but prior authorization may be required

Cameron, a retired opera enthusiast in central London, is single, but made a decision early on in his GLP-1 journey that he wouldnt be telling his closest friend, or his parents

Since then, he notes that both the FDA and European Medicines Agency (EMA) have investigated it and landed on the same conclusion: They dont think theres a cause and effect

Its defining characteristic is its mechanism of action